Co-Authors
This is a "connection" page, showing publications co-authored by Dimitrios Giannis and Mark Goldin.
Connection Strength
1.239
-
Vascular thromboembolic events following COVID-19 hospital discharge: Incidence and risk factors. Res Pract Thromb Haemost. 2021 Jul; 5(5):e12547.
Score: 0.238
-
External validation of the IMPROVE-DD risk assessment model for venous thromboembolism among inpatients with COVID-19. J Thromb Thrombolysis. 2021 Nov; 52(4):1032-1035.
Score: 0.238
-
Postdischarge thromboembolic outcomes and mortality of hospitalized patients with COVID-19: the CORE-19 registry. Blood. 2021 05 20; 137(20):2838-2847.
Score: 0.237
-
Treatment-Dose LMWH versus Prophylactic/Intermediate Dose Heparins in High-Risk COVID-19 Inpatients: Rationale and Design of the HEP-COVID Trial. Thromb Haemost. 2021 Dec; 121(12):1684-1695.
Score: 0.235
-
Incidence of Venous Thromboembolism and Mortality in Patients with Initial Presentation of COVID-19. J Thromb Thrombolysis. 2021 May; 51(4):897-901.
Score: 0.233
-
Validation of the IMPROVE-DD risk assessment model for venous thromboembolism among hospitalized patients with COVID-19. Res Pract Thromb Haemost. 2021 Feb; 5(2):296-300.
Score: 0.058